Hawaii Subject | FDA

Filter View [Reset All]
Syndicate content
StanceStateBillStatusSummary/TitleLast Actionsort icon
HISB49Intro
25%
Authorizes manufacturers of investigational drugs or biological products that are pending approval by the United States Food and Drug Administration to make the drugs or products available to terminally ill patients under certain conditions. Effectiv...
[Detail][Text][Discuss]
2025-01-24
[Hearing: Jan 29 @ 1:00 pm]
To Senate Health and Human Services Committee
HIHB650Intro
25%
Appropriates moneys to the Department of Business, Economic Development, and Tourism for providing education and support to local businesses regarding the United States Food and Drug Administration's guidance on colored sea salt.
[Detail][Text][Discuss]
2025-01-21
To House Economic Development Committee
Syndicate content
feedback